We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

Missed the ISA deadline? Start investing for next year today

You may have missed last year’s ISA deadline but there’s still time to invest this year.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The 2016/17 tax year ended at 12 o’clock last night, which means if you’re putting money aside to save in an ISA, you’ve missed the deadline. 

Luckily, ISA allowances refresh every tax year so while you may have missed last year’s decline, the countdown to the end of the 2017/18 tax year has only just started. 

It’s never too late to start saving and investing. With 12 months now left until the end of this tax year, you’ve got plenty of time to make use of the new, larger ISA allowance. Indeed, for this tax year, the allowance has been increased to £20,000, up from last year’s limit of £15,240. So, if you have money left over you didn’t manage to get into last year’s allowance, there’s plenty of additional room this time round.

Create a long-term plan 

Having a long-term savings plan is key to wealth creation, and a plan is even more important when trying to take advantage of a yearly product such as an ISA. Most people leave contributions to the last minute, which is fraught with risk. What happens if there is a delay in processing your bank transfer? Or what happens if you have to foot the bill for an unexpected, unforeseen expense? If you find yourself rushing to meet the ISA deadline every year, you could be placing unnecessary stress on yourself and your wealth.

And missing out on your ISA allowance can cost thousands. For example, let’s say a higher rate taxpayer invests £10,000 in a share yielding 5%, assuming this investor has already used up their tax-free dividend allowance, the tax on dividend income will be £162.50 per year or £1,625 over 10 years. This might not seem like much in the grand scheme of things, but such missed opportunities add up. What’s more, having to shell out an additional £162.50 per year to the taxman just because of a lack of planning seems like a complete waste of money.

Making the most of the allowance 

Starting a savings plan as early as possible is key to making the most of an ISA allowance. Most providers offer a regular investment plan allowing you to invest in companies such as GlaxoSmithKline (LSE: GSK) on a monthly basis.

Glaxo is the perfect stock for regular ISA investing. As one of the world’s largest pharmaceutical companies the business is highly defensive and Glaxo pays a quarterly dividend to shareholders, which at present works out at an annual rate of 4.8%. The payout is covered around 1.4 times by earnings per share.

Glaxo’s dividend isn’t its only attractive quality. As a pharmaceutical company, its earnings are relatively stable and are set to grow in line with the world’s ever-expanding population. The population is getting older and wealthier, two trends that are advantageous for Glaxo’s earnings as the company can sell more products at higher prices. 

After the firm’s recent restructuring, earnings growth has taken off with earnings per share up 35% last year, and growth of 8% pencilled-in for 2017. The shares currently trade at a forward PE of 14.9, which is not overly expensive for such a defensive high-yield stock.

So overall, now is the time to start investing your ISA allowance for this year and Glaxo could be the perfect place to start. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

2 UK shares to consider avoiding as the FTSE 100 extends losses

As the FTSE 100 dips for the second time this year, Mark Hartley weighs up market sentiment and considers two…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

How to invest £125 a month in UK shares to target a £39,039 annual passive income

Muhammad Cheema explains how an investor could earn the current median salary in the UK as passive income by making…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

These white-hot FTSE 250 growth shares are on sale today!

Royston Wild loves a good bargain. Here he reveals two FTSE 250 shares that all savvy UK stock investors should…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

How much do you need an ISA for a £31,352 second income?

Investing regularly in a Stocks and Shares ISA can generate a significant second income in retirement. Royston Wild explains how.

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

With the Aston Martin share price in pennies, is it in bargain territory?

With the Aston Martin share price at a fraction of what it once was, is it a bargain? Our writer…

Read more »

A hiker and their dog walking towards the mountain summit of High Spy from Maiden Moor at sunrise
Investing Articles

How I plan to lock in sustainable growth on the FTSE 100 in the coming years

Mark Hartley takes a sobering look at the future, and outlines a plan to target FTSE 100 sectors with lower…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

What are the FTSE’s most lucrative high-yield shares?

Our writer zooms in one one of a handful of high-yield FTSE 100 shares to explain why he thinks it…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Why bother with a SIPP now rather than wait 10 years?

Interested in a SIPP but putting it off to give yourself time to think? Christopher Ruane explains why that could…

Read more »